We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Trestle and Bacus Integrate Systems

By Labmedica staff writers
Posted on 01 Jul 2005
In a move designed to provide pathologists with more options, Trestle Holdings, Inc. More...
(Irvine, CA, USA) has partnered with Bacus Laboratories, Inc. (Chicago, IL, USA) to integrate the advanced digital microscope systems of Bacus with Trestle's suite of digital pathology workflow applications.

This agreement allows pathologists to use Trestle's Xcellerator application suite and connect it to a wider choice of digital microscopy devices. This integration marks a move away from proprietary formats, toward technical standards and open architecture intended to benefit users who have often been frustrated by the lack of interoperability among software and hardware. Bacus' viewing format offers compatibility with the microscopes used in the Nikon Coolscope VS systems as well as with Trestle's MedMicro products.

"As pathologists embrace digital devices and workflow applications, it is essential that the industry respond with improved plug-and-play compatibility so that users can derive more value from their investments in equipment,” stated Maurizio Vecchione, CEO of Trestle Holdings. "Now, pathologists can choose the optimal device for specialized forms of imaging and integrate their virtual microscopy data into one, consistent, standardized digital workflow solution.” Trestle Holdings develops and sells digital imaging and telemedicine products that link dispersed users with each other via information databases and analytical tools.

"There is now a recognized need to organize virtual slides in a meaningful and flexible way for storage and subsequent review by multiple parties,” observed Dr. James Bacus, president of Bacus Laboratories. "This agreement will allow both companies to focus on their respective areas of expertise.”





Related Links:
Trestle Holdings
Bacus Laboratories

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.